Market Closed -
Other stock markets
|
After market 03:30:41 pm | |||
49.01 EUR | -0.12% | 49.04 | +0.05% |
Dec. 23 | Eurofins: 4th share buyback program | CF |
Nov. 28 | EUROFINS SCIENTIFIC : NAV cut by -6.0% |
Business description: Eurofins Scientific SE
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Number of employees: 61,798
Sales by Activity: Eurofins Scientific SE
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Analytical Testing | 4.56B | 5.44B | 6.72B | 6.71B | 6.51B |
Geographical breakdown of sales: Eurofins Scientific SE
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Europe | 2.53B | 3.18B | 4.05B | 3.56B | 3.36B |
North America | 1.7B | 1.92B | 2.18B | 2.53B | 2.54B |
Rest of The World | 401M | 425M | 603M | 733M | 725M |
Group Service Functions | - | - | - | - | 100K |
Inter-Segment Revenues | -73.4M | -84.2M | -114M | -112M | -111M |
Managers: Eurofins Scientific SE
Director | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 62 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
COO | Chief Operating Officer | - | 2019-09-30 |
Asaf Azulay
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 42 | - |
Members of the board: Eurofins Scientific SE
Manager | Title | Age | Since |
---|---|---|---|
Gilles Martin
CHM | Chairman | 62 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 59 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 59 | 1990-12-31 |
Director/Board Member | 61 | 2017-04-19 | |
Pascal Rakovsky
BRD | Director/Board Member | 66 | 2020-05-31 |
Evie Roos
BRD | Director/Board Member | 57 | - |
Ivo Rauh
BRD | Director/Board Member | - | - |
Erica Monfardini
BRD | Director/Board Member | - | - |
Holdings: Eurofins Scientific SE
Name | Equities | % | Valuation |
---|---|---|---|
EUROFINS CEREP 95.76% | 4,831 | 95.76% | 98,049,014 $ |
VIMTA LABS LIMITED 19.82% | 4,403,668 | 19.82% | 51,192,156 $ |
EUROFINS SCIENTIFIC SE 0.50% | 955,858 | 0.50% | 48,806,597 $ |
Company details: Eurofins Scientific SE
Group companies: Eurofins Scientific SE
Name | Category and Sector |
---|---|
Eurofins GeneScan Holding GmbH
Eurofins GeneScan Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins GeneScan Holding GmbH is a world leader in food, environment, pharma product testing & agroscience CRO services. The company is based in Freiburg im Breisgau, Germany. The German company has a network of more than 1,000 independent companies (900 laboratories) in 61 countries, offering over 200,000 analytical methods. The company was founded in 2011 and the CEO is Gilles G. Martin. |
Miscellaneous Commercial Services
|
Eurofins Discovery Services LUX Holding SARL
Eurofins Discovery Services LUX Holding SARL Financial ConglomeratesFinance Part of Eurofins Scientific SE, Eurofins Discovery Services LUX Holding SARL functions as an investment holding Luxembourger company. The company is based in Luxembourg, Luxembourg. |
Financial Conglomerates
|
Wiener Neudorf Palmersstraße Real Estate GmbH
|
Other Healthcare Facilities & Services
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.12% | -1.31% | -14.23% | -48.41% | 9.44B | ||
+0.79% | +3.15% | +9.06% | +20.38% | 76.7B | ||
+6.05% | +10.65% | -34.52% | -51.87% | 60.42B | ||
-1.13% | +4.14% | +2.28% | +75.50% | 27.99B | ||
-3.37% | -1.17% | +170.61% | +149.07% | 23.1B | ||
-1.54% | +0.94% | +28.16% | -5.95% | 20.22B | ||
+0.13% | +1.46% | +5.19% | -16.03% | 19.4B | ||
+1.11% | +1.06% | +14.97% | +6.12% | 16.94B | ||
-1.47% | -1.96% | +19.02% | -24.78% | 13.24B | ||
-5.83% | -7.99% | +46.80% | +168.53% | 12.97B | ||
Average | -0.48% | +2.24% | +24.73% | +27.26% | 28.04B | |
Weighted average by Cap. | +0.79% | +2.92% | +15.20% | +18.04% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
- Company Eurofins Scientific SE